P-glycoprotein down-regulates expression of breast cancer resistance protein in a drug-free state

FEBS Letters

Volumn 582, Issue 17, 2008, Pages 2595-2600

  Bark, Hyun ^a   Xu, Hai Dong ^a   Kim, Sang Hyun ^b   Yun, Jisoo ^a   Choi, Cheol Hee ^a  

^a Chosun University College of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Breast cancer resistance protein; c Jun; c Jun NH2 terminal kinase; P glycoprotein; PSC833; Verapamil

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BREAST CANCER RESISTANCE PROTEIN; DOXORUBICIN; GLYCOPROTEIN P; PROTEIN C JUN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; VALSPODAR; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANTHRACENES; ANTIBIOTICS, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CYCLOSPORINS; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; P-GLYCOPROTEIN;

EID: 46749098226     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.06.036     Document Type: Article

References (19)

1. Riordan J.R., and Ling V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem. 254 (1979) 12701-12705
2. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., and Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 (1992) 1650-1654
3. Maliepaard M., van Gastelen M.A., de Jong L.A., Pluim D., van Waardenburg R.C., Ruevekamp-Helmers M.C., Floot B.G., and Schellens J.H. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 59 (1999) 4559-4563
4. Bodo A., Bakos E., Szeri F., Varadi A., and Sarkadi B. The role of multidrug transporters in drug availability metabolism and toxicity. Toxicol. Lett. 140-141 (2003) 133-143
5. Vos T.A., Hooiveld G.J., Koning H., Childs S., Meijer D.K., Moshage H., Jansen P.L., and Muller M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28 (1998) 1637-1644
6. Pieters R., Huismans D.R., Leyva A., and Veerman A.J. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. Cancer Lett. 41 (1988) 323-332
7. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24 (1979) 145-149
8. Choi C.H., Kim H.S., Rha H.S., Jeong J.H., Park Y.H., Min Y.D., Kee K.H., and Lim D.Y. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines. Mol. Cell 9 (1999) 314-319
9. Kim D.K., and Lee Y.M. Requirement of c-Jun transcription factor on the mouse mast cell protease-6 expression in the mast cells. Arch. Biochem. Biophys. 431 (2004) 71-78
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
11. Zhou J., Liu M., Aneja R., Chandra R., Lage H., and Joshi H.C. Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res. 66 (2006) 445-452
12. Cisternino S., Mercier C., Bourasset F., Roux F., and Scherrmann J.M. Expression, up-regulation and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res. 64 (2004) 3296-3301
13. Bordow S.B., Haber M., Madafiglio J., Cheung B., Marshall G.M., and Norris M.D. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res. 54 (1994) 5036-5040
14. Brock I., Hipfner D.R., Nielsen B.S., Jensen P.B., Deeley R.G., Cole S.P., and Sehested M. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res. 55 (1995) 459-462
15. Choi C.H., Kim H.S., Rha H.S., Jeong J.H., Park Y.H., Min Y.D., Kee K.H., and Lim D.Y. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines. Mol. Cell 9 (1999) 314-319
16. Friedrich R.E., Punke C., and Reymann A. Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma. In Vivo 18 (2004) 133-147
17. Stein U., Walther W., Lemm M., Naundorf H., and Fichtner I. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo. Int. J. Cancer 72 (1997) 885-891
18. Galimberti S., Guerrini F., Palumbo G.A., Consoli U., Fazzi R., Morabito F., Santini V., and Petrini M. Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients. Leuk. Res. 28 (2004) 367-372
19. Kanzaki A., Toi M., Nakayama K., Bando H., Mutoh M., Uchida T., Fukumoto M., and Takebayashi Y. Expression of multidrug resistance-related transporters in human breast carcinoma. Jpn. J. Cancer Res. 92 (2001) 452-458